China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
106 hedge funds and large institutions have $1.54B invested in China Biologic Products Holdings, Inc. in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 36 reducing their positions, and 28 closing their positions.
248% more call options, than puts
Call options by funds: $28.6M | Put options by funds: $8.2M
0% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 36
4% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 28
3% less funds holding
Funds holding: 109 → 106 (-3)
19% less capital invested
Capital invested by funds: $1.9B → $1.54B (-$360M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$34.3M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$21M |
| 3 |
Bank of New York Mellon
New York
|
+$16.2M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$15.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KM
Kylin Management
New York
|
-$21.7M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$19.2M |
| 3 |
PA
Perceptive Advisors
New York
|
-$17M |
| 4 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$16.1M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$12.5M |
CBPO Hedge Fund Activity: Q3 2015 in Review
106 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q3 2015, worth a combined $1.54B — down 19% from $1.9B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CBPO and 27 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 36 added.
The largest buyer was Wasatch Advisors, opening a new position worth an estimated $34.3M. The largest seller was Kylin Management, exiting entirely with an estimated $21.7M sold.
- 106 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q3 2015, down from 109 in Q2 2015.
- Funds reported $1.54B of China Biologic Products Holdings, Inc. stock for Q3 2015, down 19% quarter-over-quarter.
- 27 funds opened new China Biologic Products Holdings, Inc. positions in Q3 2015 and 28 closed out, a net change of -1 holder.
- The largest China Biologic Products Holdings, Inc. buyer in Q3 2015 was Wasatch Advisors, an estimated $34.3M added.
- The largest China Biologic Products Holdings, Inc. seller in Q3 2015 was Kylin Management, an estimated $21.7M sold.
Based on aggregated 13F filings for Q3 2015.